Cluster Headache Market Is Anticipated To Witness High Growth Owing To Increasing Prevalence Of Cluster Headache Disorder

Cluster Headache Market

 

Cluster headache, also known as histamine cephalgia, is a neurological disorder characterized by severe pain on one side of the head. The pain is generally described as boring, stabbing, or sharp and usually occurs behind or around one eye. The exact cause for cluster headaches is unknown, however, genetic and environmental factors are believed to play a role. Currently available treatment options for cluster headache include oxygen therapy, triptans, corticosteroids, verapamil, topiramate, and ergotamine. However, these therapies have limited effectiveness, unpleasant side effects, and discontinuation risks. This has increased the demand for alternative treatment options such as non-invasive neurostimulation devices that can deliver targeted stimulation to blocks pain signals.

The Global Cluster Headache Market is estimated to be valued at US$ 463.25 Bn in 2024 and is expected to exhibit a CAGR of 26% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Cluster Headache Market Demand are AWIRE Technology Corp., STARNEX Co., Ltd., Theatro, and OrionLabs, Inc. These companies are focusing on developing advanced neurostimulation devices for cluster headache treatment. For instance, in 2021, Theatro launched a new non-invasive vagus nerve stimulation device for preventive cluster headache treatment.

The rapidly growing cluster headache patient pool worldwide presents significant growth opportunities in the market. According to estimates, over 1 million people in the US and over 4 million people globally suffer from cluster headache. However, only about 15% receive proper treatment due to low awareness about treatment options and availability of specialized care.

North America holds the largest share of the global cluster headache market, followed by Europe. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period owing to improving access to advanced treatment such as neurostimulation therapies and increasing focus of leading players on emerging markets.

Market Drivers

Increasing prevalence of cluster headache disorder globally is a major market driver. Rising risk factors like family history of cluster headache, smoking, and excessive alcohol consumption are contributing to the growing disease burden. According to a study published in Neurology, the 1-year prevalence of cluster headache is 43 per 100,000 population. Furthermore, growing awareness about alternative treatment options and early adoption of neurostimulation devices will support the market growth.

Market Restraints

High cost of neurostimulation devices used for preventive cluster headache treatment poses a major challenge in developing markets. On an average, non-invasive vagus nerve stimulators cost between US$ 6,000–8,000, limiting their availability. Secondly, lack of healthcare reimbursement policies for cluster headache therapies in most countries negatively impacts the market.

Segment Analysis

The episodic cluster headache segment currently dominates the cluster headache market. Cluster headache occurs in episodic or chronic form. Episodic cluster headaches occur in distinct periods with pain-free periods in between. It affects nearly 75-80% of the total cluster headache population. As episodic cluster headache has distinct periods of attacks as well as remission, it can be effectively treated and managed through acute and preventive treatment approaches using triptans, oxygen therapy, and other medications during active cluster periods.

Global Analysis

The North America region holds the largest share of the cluster headache market and is estimated to grow steadily during the forecast period. This is attributed to factors such rising disease prevalence, growing awareness about the condition and treatment options available, presence of well-established healthcare infrastructure and favorable reimbursement policies, availability of expensive triptans and other treatment options. Europe is the second largest market for cluster headaches. Availability of strategic initiatives and programs for improving patient care and medical access boosts market growth in the region. Developing regions such as Asia Pacific are expected to offer lucrative opportunities. Rising healthcare expenditure, increasing focus on neurological disorders, expanding medical tourism industry are supporting the regional market growth.

Get more insights on Cluster Headache Market

Comments

Post a Comment

Popular posts from this blog

Unveiling the Growth Trajectory: Passive Optical Network Equipment Market Analysis

Image
  Passive Optical Network Equipment Market  The increased demand for fiber-optic technology and high-speed internet access has resulted in a significant growth in the passive optical network equipment market in recent years. Compared to conventional copper-based networks, Passive Optical Network (PON) technology has a number of benefits, including increased bandwidth, decreased latency, and cheaper maintenance costs. To address the growing demand for bandwidth-intensive applications and services, telecom operators and businesses are investing more in PON equipment to upgrade their network infrastructure. The Passive Optical Network Equipment Market is estimated to be valued at US$ 26.41 Billion in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2031. Market Drivers Several factors are driving the growth of the Passive Optical Network Equipment Market. Firstly, the exponential growth of data traffic due to the proliferation of connected devices...
Read more

Chemiluminescence Imaging Market Poised To Grow Substantially Due To Advancements In Medical Imaging Techniques

Image
Chemiluminescence Imaging Market   The global Chemiluminescence Imaging market size is estimated to be valued at US$ 15.21 billion in 2024 and is expected to exhibit a CAGR of 10% over the forecast period of 2024 to 2031. Chemiluminescence refers to the process of light emission resulting from a chemical reaction. In chemiluminescence imaging, chemical compounds are used to emit light, which is then captured by imaging devices to produce images. Chemiluminescence imaging finds widespread applications in molecular biology research, medical research, and medical diagnostics. The increasing demand for accurate and non-invasive diagnostic tools is a key factor driving the adoption of chemiluminescence imaging systems in the healthcare sector. Key Takeaways Key players operating in the Chemiluminescence Imaging Market Share are Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Bracco, Cardinal Health, Eckert & Ziegle, Fusion Pharmaceuticals, IBA Worldwide, NorthStar ...
Read more

Shaping the Future: An In-Depth Analysis of the Automotive Hydroformed Parts Market

Image
   Automotive Hydroformed Parts Market A sizeable portion of the automotive sector is represented by the automotive hydroformed parts market, which is distinguished by the cutting-edge hydroforming technique that shapes metal components using high-pressure hydraulic fluid. This process improves component strength-to-weight ratio, which is essential for raising vehicle performance and fuel economy. The market for automotive hydroformed parts has expanded significantly as a result of consumers' growing need for strong, lightweight car parts. The Automotive Hydroformed Parts Market is estimated to be valued at US$ 14.85 Bn in 2024 and is expected to exhibit a CAGR of 7.7 % over the forecast period 2024 to 2031. Market Drivers The primary factor is the automotive industry's shift towards lightweight vehicles to meet stringent emission standards and fuel efficiency targets. Hydroforming technology offers an optimal solution by reducing the weight of parts without compromising stre...
Read more